Robust and reproducible population receptive field mapping in patients with retinal pathologies - Report - MDSpire

Robust and reproducible population receptive field mapping in patients with retinal pathologies

  • By

  • Maximilian Pawloff

  • David Linhardt

  • Michael Woletz

  • Marlene Hollaus

  • Georgios Mylonas

  • Graham E. Holder

  • Stefan Sacu

  • Christian Windischberger

  • Markus Ritter

  • June 4, 2026

  • 0 min

Share

Reliable and consistent mapping of population receptive fields in retinal disorders

Overview

This study evaluates the reproducibility of population receptive field (pRF) mapping using 7 Tesla fMRI in patients with Stargardt disease and geographic atrophy. It highlights the potential of pRF mapping as an objective tool for assessing visual field representation in retinal disorders.

Background

Retinal disorders significantly impact visual function, and accurate assessment methods are crucial for diagnosis and treatment planning. Traditional subjective methods, such as perimetry, can be influenced by various factors, leading to variability in results. The advent of fMRI provides an objective means to assess neural responses to visual stimuli, which may enhance our understanding of visual field representation in patients with retinal diseases.

Data Highlights

No numerical data was provided in the article.

Key Findings

  • The study involved 22 patients: 11 with Stargardt disease and 11 with geographic atrophy.
  • pRF mapping at 7 Tesla demonstrated high reproducibility in healthy participants, but similar data in clinical populations was previously lacking.
  • Both intrasession and intersession reproducibility of pRF mapping were assessed in patients with retinal disorders.
  • Retinotopic mapping revealed distinct cortical representations corresponding to retinal lesions.
  • Higher magnetic field strengths (7 Tesla) yield improved resolution of activation maps compared to lower field strengths.

Clinical Implications

The findings suggest that pRF mapping could serve as a reliable objective tool for evaluating visual field representation in patients with retinal disorders. This may facilitate better understanding and monitoring of disease progression and treatment effects.

Conclusion

The study underscores the potential of 7 Tesla fMRI pRF mapping as a reproducible method for assessing visual field representation in patients with retinal disorders, paving the way for future research in this area.

Related Resources & Content

  1. Eye, Nature, 2026 -- Visual acuities in patients with autosomal recessive retinitis pigmentosa associated with four rod phototransduction genes
  2. Optometric Management, 2025 -- Case Study: Electroretinography in Diabetic Retinopathy
  3. Retinal Physician, 2019 -- Ultrawidefield Imaging for Diabetic Retinopathy
  4. EURETINA, 2025 -- EURETINA IRD Consensus Supplement
  5. ISCEV, 2025 -- ISCEV standard for clinical visual evoked potentials (2025 update)
  6. the ophthalmologist — Optoretinography: The Next Frontier in Photoreceptor Analysis? 
  7. Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial
  8. Use of functional magnetic resonance imaging in the evaluation of neural plasticity in macular degeneration
  9. https://eplatform.euretina.org/wp-content/uploads/2025/10/EURETINA_IRD-Consensus-Supplement.pdf
  10. ISCEV standard for clinical visual evoked potentials (2025 update) - PMC
  11. Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE - ScienceDirect
  12. Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial - PubMed
  13. Automated OCT-tailored and same-visit biomarker-targeted microperimetry in geographic atrophy - PubMed
  14. GEM-pRF: GPU-empowered mapping of population receptive fields for large-scale fMRI analysis - PubMed

Original Source(s)

Related Content